Location of affected unit(s):
Manufacture of pharmaceuticals, medicinal chemical and botanical products
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
Planned Job Reductions min:
Planned Job Reductions max:
Type of Restructuring:
Organon has developed innovative prescription medicines for gynecology, mental health, anesthesia, and for cardiovascular diseases. The company currently employs around 13,000 people in more than 50 countries. Worlwide, Akzo Nobel decided to suppress some 500 jobs. The management will use early retirements and other ways to avoid direct dismissals. In April 2003, 60 more jobs suppressed in Oss.
02-04-2003De Financiële Telegraaf